课题基金 / 基金详情

FIBROMYALGIA, DEPRESSION AND MYOFASCIAL TMD

FIBROMYALGIA, DEPRESSION AND MYOFASCIAL TMD
纤维肌痛、抑郁症和肌筋膜 TMD
批准号:
6516583
负责人:
KAREN G. RAPHAEL
金额:
$17.54万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2004-06-30

项目摘要

项目成果

KAREN G. RAPHAEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (taken from the application): The well-established comorbidity of fibromyalgia (FMS) and major depression (MDD) has motivated speculations about the direction of the relationship. Three principal hypotheses to be tested here are: (l)that FMS is a variant of depression; (2) that MDD in FMS sufferers is a reaction to FMS; and (3) that high rates of MDD in FMS patients are an artifact of studying treatment-seekers. The proposed study's first aim is to support one and refute other hypotheses, by conducting a family study. Community women meeting criteria for FMS (n= 120) will be stratified so that half (n=60) have a lifetime history of MDD. Demographically-matched non-FMS controls (n= 120) from the same sampling frame will also be stratified on MDD status. Direct psychiatric interviews and physical examinations will be conducted with probands and all their available adult first degree relatives. To support the first hypothesis, familial MDD rates should be elevated in FMS probands, even among probands with no personal depression histories; to support the second, probands with FMS and MDD should have low familial depression rates, as their depression should be more likely reactive to FMS; to support the last, familial MDD should be elevated in probands with MDD histories themselves, regardless of FMS status. A second aim, prompted by the comorbidity of FMS and myofascial temporomandibular disorder (M/TMD), is test (1) whether M/TMD is a regional manifestation of FMS or (2) whether M/TMD comorbid with FMS is different from M/TMD expressed as a regional disorder. To accomplish this aim, we will first reconfirm that FMS is familial, utilizing data gathered to satisfy the first aim. Second, we will reconstitute the groups from Aim 1, according to both FMS and M/TMD status. Rates of familial M/TMD in FMS and control probands, broken down by proband M/TMD status, will be examined. If M/TMD is found in the family of FMS probands, regardless of proband M/TMD status, this will support the first hypothesis. If only FMS probands have familial M/TMD but M/TMD probands do not, this will support the 2nd hypothesis and indicate that the two disorders are provoked through different pathogenic processes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preliminary Safety Study of Botulinum Toxin for Treatment of Myofascial TMJD Pain
  • 批准号:
    9113560
  • 项目类别:
  • 资助金额:
    $92.98万
  • 财政年份:
    2014
  • 负责人:
    KAREN G. RAPHAEL
  • 依托单位:
Preliminary Safety Study of Botulinum Toxin for Treatment of Myofascial TMJD Pain
  • 批准号:
    9020301
  • 项目类别:
  • 资助金额:
    $7.03万
  • 财政年份:
    2014
  • 负责人:
    KAREN G. RAPHAEL
  • 依托单位:
Randomized controlled clinical trial of botulinum toxin for myofascial TMJD pain
  • 批准号:
    8384755
  • 项目类别:
  • 资助金额:
    $23.55万
  • 财政年份:
    2012
  • 负责人:
    KAREN G. RAPHAEL
  • 依托单位:
Sleep Bruxism and Central Sensitization in Myofascial Face Pain
海外基金